Rooney, J. E., Knapp, J. R., Hodges, B. L., Wuebbles, R. D., & Burkin, D. J. (2012). Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular Dystrophy. American Society for Investigative Pathology.

Rooney, Jachinta E., Jolie R. Knapp, Bradley L. Hodges, Ryan D. Wuebbles, and Dean J. Burkin. Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular Dystrophy. American Society for Investigative Pathology, 2012.

Rooney, Jachinta E., et al. Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular Dystrophy. American Society for Investigative Pathology, 2012.